Status:
COMPLETED
Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Multiple Myeloma
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
This is a prospective randomized controlled trial to obtain preliminary data for the design of a future definitive efficacy study. A randomized controlled trial is needed because comparison to histori...
Eligibility Criteria
Inclusion
- Age 21 or above (those age below 21 are usually treated in the Pediatric Transplant Service)
- Diagnosis of multiple myeloma
- Scheduled to receive conditioning chemotherapy followed by upfront or salvage autologous peripheral blood hematopoietic stem cell transplantation
Exclusion
- Absolute neutrophil count less than 200/microliter
- Platelet count less than 20,000/microliter
- Acupuncture treatment in the preceding 4 weeks prior to Day 1
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2021
Estimated Enrollment :
63 Patients enrolled
Trial Details
Trial ID
NCT01811862
Start Date
March 1 2013
End Date
December 10 2021
Last Update
December 14 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065